Title: Glycoprotein IIb/IIIa inhibitors and drug-eluting stents: why and when Created Date: 9/19/2006 8:05:43 AM Document presentation format: Presentazione su schermo
When PCI in NSTEMI? Giuseppe Biondi Zoccai, MD Department of Medico-Surgical Sciences and Biotechnologies Sapienza University of Rome gbiondizoccai@gmail.com
Gender-related differences in carotid plaque features: focus on instability and inflammation Giuseppe Biondi Zoccai, MD University of Modena and Reggio Emilia, Modena ...
Cardiology Faculty of Medicine and Surgery University of Turin Heart failure (3 of 3): treatment Giuseppe Biondi Zoccai Division of Cardiology 1, Ospedale San
Why are drug-eluting stents safer than bare-metal stents? Giuseppe Biondi Zoccai, MD Sapienza University of Rome, Rome, Italy METCARDIO, Ospedaletti, Italy
Meta-analysis Principles and practice in cardiovascular research Giuseppe Biondi Zoccai Istituto di Cardiologia, Universit di Torino Disclosure No funding or ...
Retrograde Percutaneous Recanalization Of Coronary Chronic Total ... an uncommon case of retrograde recanalization of chronic total occlusion of the left ...
... Group randomized 3,867 newly diagnosed patients with type 2 diabetes to intensive treatment with a sulphonylurea or insulin vs. conventional treatment with ...
Metabolic Activation and Idiosycratic Drug Toxicity: By Avoiding Structural Alerts, Do We Mitigate Risks? Amit S. Kalgutkar, Ph.D. Pfizer Global Research and Development
Limitaciones de la medicina basada en las pruebas ... Limitaciones de la medicina basada en las pruebas. Sesi n Bibliogr fica 2301. PREGUNTA CL NICA ...